Amoxicillin-Clavulanate at High Dose
For an 88-year-old patient with sinus infections, prescribe high-dose amoxicillin-clavulanate (2 g orally twice daily) as first-line therapy. This patient's age >65 years places her at high risk for infection with resistant organisms, making amoxicillin-clavulanate superior to amoxicillin alone 1.
Why High-Dose Amoxicillin-Clavulanate for This Patient
The 2015 guideline explicitly identifies age older than 65 years as a factor requiring amoxicillin-clavulanate instead of plain amoxicillin 1. At 88 years old, this patient meets criteria for:
- High risk of penicillin-resistant Streptococcus pneumoniae infection
- Presence of comorbidity or extremes of life category
- Need for broader coverage against β-lactamase-producing organisms (Haemophilus influenzae, Moraxella catarrhalis)
The high-dose regimen (2 g twice daily, not standard dose) is specifically recommended for patients >65 years to adequately cover penicillin-nonsusceptible pneumococci 1.
Treatment Duration and Monitoring
- Duration: 5-10 days is appropriate; shorter courses (5 days) show similar efficacy with fewer adverse events 1
- Reassess at 72 hours: If no improvement or worsening occurs, reevaluate for complications or alternative diagnoses 2
- Common adverse effects: Diarrhea, nausea, vaginitis (15-40% incidence) 1—particularly relevant in elderly patients
Alternative Options If Penicillin-Allergic
If this patient has a documented penicillin allergy:
- Respiratory fluoroquinolone (levofloxacin 500 mg daily or moxifloxacin 400 mg daily) 1
- Doxycycline as another alternative 1
- Avoid macrolides (azithromycin, clarithromycin)—>40% resistance rates in S. pneumoniae make them inappropriate 1
Critical Caveat About Fluoroquinolones in Elderly
While fluoroquinolones are effective alternatives, exercise caution in this 88-year-old patient due to:
- Increased risk of Achilles tendon rupture in elderly patients 2
- Higher adverse event rates compared to amoxicillin-clavulanate 1
- Should be reserved for true penicillin allergy, not first-line choice
What NOT to Prescribe
Do not use the following due to high resistance rates 1:
- Plain amoxicillin (inadequate for age >65)
- Trimethoprim-sulfamethoxazole (50% S. pneumoniae resistance)
- Macrolides (>40% resistance)
- First-generation cephalosporins
Confirming the Diagnosis
Before prescribing antibiotics, ensure this represents acute bacterial rhinosinusitis (ABRS) rather than viral infection:
- Symptoms persisting >10 days without improvement, OR
- Severe symptoms (high fever >39°C + purulent discharge) for ≥3 consecutive days, OR
- "Double worsening": initial improvement followed by symptom worsening 1, 3
If symptoms are <10 days and mild, this is likely viral—watchful waiting without antibiotics is appropriate 1, 3.